Cholesterol synthesis inhibitors protect against platelet-activating factor-induced neuronal damage

Journal of Neuroinflammation

Volumn 4, Issue , 2007, Pages

  Bate, Clive ^a   Rumbold, Louis ^a   Williams, Alun ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; NEUROTOXIN; SIMVASTATIN; SQUALESTATIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; HYPOCHOLESTEROLEMIC AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CHOLESTEROL SYNTHESIS; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; LIPID RAFT; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PROTEIN DETERMINATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; HUMAN; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CELL SURVIVAL; CELLS, CULTURED; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; NEURONS; PLATELET ACTIVATING FACTOR;

EID: 33846821715     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-4-5     Document Type: Article

References (23)

1. Puglielli L Tanzi RE Kovacs DM Alzheimer's disease: The cholesterol connection NatNeurosci 2003 6 4 345-351
2. Wolozin B Kellman W Ruosseau P Celesia GG Siegel G Decreased prevalence of alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors ArchNeurol 2000 57 10 1439-1443
3. Hess DC Fagan SC Pharmacology and clinical experience with simvastatin ExpertOpinPharmacother 2001 2 1 153-163
4. Maltese WA Sheridan KM Isoprenylated proteins in cultured cells: subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation JCell Physiol 1987 133 3 471-481 10.1002/jcp.1041330307
5. Cole SL Vassar R Isoprenoids and Alzheimer's disease: A complex relationship Neurobiology of Disease 2006 22 2 209-222 10.1016/ j.nbd.2005.11.007 16406223
6. Baxter A Fitzgerald BJ Hutson JL McCarthy AD Motteram JM Ross BC Sapra M Snowden MA Watson NS Williams RJ Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo JBiolChem 1992 267 17 11705-11708
7. Perry SW Hamilton JA Tjoelker LW Dbaibo G Dzenko KA Epstein LG Hannun Y Whittaker JS Dewhurst S Gelbard HA Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis JBiolChem 1998 273 28 17660-17664
8. Bazan NG The neuromessenger platelet-activating factor in plasticity and neurodegeneration ProgBrain Res 1998 118 281-291
9. Bate C Salmona M Williams A The role of platelet activating factor in prion and amyloid-b neurotoxicity Neuroreport 2004 15 509-513 10.1097/ 00001756-200403010-00025 15094513
10. Shukla SD Platelet-activating factor receptor and signal transduction mechanisms The FASEB Journal 1992 6 6 2296-2301 1312046
11. Clark GD Zorumski CF McNeil RS Happel LT Ovella T McGuire S Bix GJ Swann JW Neuronal platelet-activating factor receptor signal transduction involves a pertussis toxin-sensitive G-protein NeurochemRes 2000 25 5 603-611 10.1023/A:1007598617374
12. Wiesner DA Dawson G Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway J Neurochem 1996 66 4 1418-1425 8627293
13. Hatae T Wada M Yokoyama C Shimonishi M Tanabe T Prostacyclin-dependent apoptosis mediated by PPAR delta JBiolChem 2001 276 49 46260-46267
14. Montine TJ Sidell KR Crews BC Markesbery WR Marnett LJ Roberts LJ Morrow JD Elevated CSF prostaglandin E2 levels in patients with probable AD Neurology 1999 53 7 1495-1498 10534257
15. Brown MS Goldstein JL A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood ProcNatlAcadSciUSA 1999 96 20 11041-11048
16. Bazan NG Rodriguez TEB Allan G Mediators of injury in neurotrauma: intracellular signal transduction and gene expression JNeurotrauma 1995 12 5 791 814
17. Aihara M Ishii S Kume K Shimizu T Interaction between neurone and microglia mediated by platelet-activating factor Genes Cells 2000 5 5 397-406 10.1046/j.1365-2443.2000.00333.x 10886367
18. Prescott SM Zimmerman GA Stafforini DM McIntyre TM Platelet-activating factor and related lipid mediators AnnuRevBiochem 2000 69 419-445
19. Zhang FL Casey PJ Protein prenylation: Molecular mechanisms and functional consequences AnnuRevBiochem 1996 65: 241-269
20. Diomede L Albani D Sottocorno M Donati MB Bianchi M Fruscella P Salmona M In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products ArteriosclerThrombVascBiol 2001 21 8 1327-1332
21. Paris D Townsend KP Humphrey J Obregon DF Yokota K Mullan M Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae Atherosclerosis 2002 161 293-299 10.1016/S0021-9150(01)00660-8 11888511
22. Bate C Salmona M Diomede L Williams A Squalestatin cures prion-infected neurones and protects against prion neurotoxicity JBiolChem 2004 279 (15) 14983-14990
23. Oh P Schnitzer JE Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default MolBiolCell 2001 12 3 685-698